On the prevalence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome after a SARS-CoV-2 infection. Sepulveda N, Westermeier F. J Infect 2024;89:106353.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sepulveda N, Westermeier F. On the prevalence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome after a SARS-CoV-2 infection. J Infect 2024;89:106353.
PMID: 39557089